Wolverine Trading’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-20,500
Closed -$147K 5973
2025
Q2
$147K Buy
20,500
+600
+3% +$4.84K ﹤0.01% 4048
2025
Q1
$191K Buy
+19,900
New +$248K ﹤0.01% 3977
2022
Q2
Sell
-18,400
Closed -$238K 5310
2022
Q1
$238K Buy
+18,400
New +$387K ﹤0.01% 4186
2020
Q4
Sell
-5,500
Closed -$203K 5243
2020
Q3
$203K Buy
+5,500
New +$204K ﹤0.01% 3853
2019
Q4
Sell
-23,700
Closed -$453K 5007
2019
Q3
$453K Buy
+23,700
New +$556K ﹤0.01% 2742
2017
Q1
Sell
-10,400
Closed -$89K 4754
2016
Q4
$89K Buy
+10,400
New +$89.1K ﹤0.01% 4090

Other funds holding NEO

Wolverine Trading's NEO Position: Q4 2019 in Review

Wolverine Trading sold out of NeoGenomics (NEO) in Q4 2019, closing a stake of 21,252 shares — an estimated $406K sold.

Wolverine Trading first reported a position in NEO in Q3 2019 and held it in 1 quarter. The position peaked at $406K in Q3 2019. 261 funds tracked by Wall St. Rank hold NEO as of Q4 2019.

  • Wolverine Trading reported no remaining NeoGenomics position as of Q4 2019 after selling out during the quarter.
  • Wolverine Trading sold 21,252 NeoGenomics shares in Q4 2019, an estimated $406K.
  • Wolverine Trading first reported a position in NeoGenomics in Q3 2019 and held it in 1 quarter.
  • Wolverine Trading's NeoGenomics position peaked at $406K in Q3 2019.
  • 261 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2019.

Based on Wolverine Trading's 13F filing for Q4 2019, filed 12 Feb 2020.